title: Response to growth hormone treatment in a patient with 18p-syndrome.
abstract: A female patient with known chromosomes 18p- and 14 p- presented with severe growth failure at age 2-9/12 years. Growth hormone (GH), at 0.3 mg/kg/week, was initiated at age 6-3/12 years. Her linear growth improved dramatically over the subsequent 7 years. We present details of her course and review the medical literature on the use of GH in patients with 18p-syndrome.
authors: Cleveland Clinic, Cleveland, OH, USA. rogersd@ccf.org
authors: Douglas G
authors: DG
authors: Rogers
authors: Ramachandra S
authors: RS
authors: Aswini
mesh_terms: D002872:Chromosome Deletion; D002887:Chromosomes, Human, Pair 18; D005260:Female; D019382:Human Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn
chemical_list: D019382:Human Growth Hormone